Benzinga's Top #PreMarket Losers

Cellectis SA (ADR) CLLS shares dropped 7.68 percent to $44.00 in pre-market. The Financial Times reported Thursday that the company was in sales talks with Pfizer Inc. PFE among potential buyers. Eleven Biotherapeutics Inc EBIO fell 3.51 percent to $2.75 in pre-market trading after dropping 3.39 percent on Thursday. Cyberark Software Ltd CYBR shares declined 3.27 percent to $62.16 in pre-market trading after the company announced up to $250 million secondary offering. Himax Technologies, Inc. (ADR) HIMX shares fell 3.22 percent to $6.32 in pre-market trading. Chardan Capital downgraded Himax Technologies from Neutral to Sell. Splunk Inc SPLK shares tumbled 2.21 percent to $69.50 in pre-market trading. Splunk reported a narrower-than-expected loss for the first quarter and lifted its revenue forecast for the year.